España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Biomarin Pharmaceutical
BMRN
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$80.97
-1.25
-1.51%
At Close: -
$80.97
0
0.00%
After Hours: 1:00 PM EDT
15 minutes delayed
Get Report
Watch
Biomarin Pharmaceutical (BMRN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Biomarin Pharmaceutical (NASDAQ:BMRN) Stock
Biomarin Pharmaceutical Stock (NASDAQ: BMRN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, June 27, 2024
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
Benzinga Insights
Wells Fargo Maintains Overweight on Biomarin ...
Benzinga Newsdesk
Monday, June 17, 2024
BioMarin Presents Data Highlighting Impact Of...
Benzinga Newsdesk
Monday, June 10, 2024
BioMarin Pharmaceutical shares are trading hi...
Benzinga Newsdesk
Friday, June 07, 2024
BioMarin Presents New Phase 3, 4-Year Data Un...
Benzinga Newsdesk
Wednesday, June 05, 2024
RICHARD MEIER At Biomarin Pharmaceutical Capitalizes: Options Exercised, Resulting In $104K
Benzinga Insights
ELAINE HERON Exercises Options, Realizes $79K
Benzinga Insights
Tuesday, June 04, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Tuesday, May 28, 2024
Looking Into Biomarin Pharmaceutical's Recent Short Interest
Benzinga Insights
Sunday, May 19, 2024
Li Auto Was One Of The Worst-Performing Stocks Last Week: Are These 10 Large-Cap Stocks Losers In Your Portfolio? (May 12-May 18, 2024)
Lekha Gupta
Friday, May 17, 2024
Walmart To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
Baird Downgrades Biomarin Pharmaceutical to N...
Benzinga Newsdesk
Wednesday, May 15, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Tuesday, May 14, 2024
BioMarin Pharmaceutical To Cut About 170 Empl...
Benzinga Newsdesk
Analyst Ratings For Biomarin Pharmaceutical
Benzinga Insights
Evercore ISI Group Initiates Coverage On Biom...
Benzinga Newsdesk
Thursday, May 09, 2024
(BMRN) - Analyzing Biomarin Pharmaceutical's Short Interest
Benzinga Insights
Monday, May 06, 2024
Reported Saturday, BioMarin Presented New Dat...
Benzinga Newsdesk
Friday, April 26, 2024
Morgan Stanley Maintains Overweight on Biomar...
Benzinga Newsdesk
Canaccord Genuity Maintains Hold on Biomarin ...
Benzinga Newsdesk
Thursday, April 25, 2024
Citigroup Maintains Neutral on Biomarin Pharm...
Benzinga Newsdesk
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Deep Dive Into Biomarin Pharmaceutical Stock: Analyst Perspectives (8 Ratings)
Benzinga Insights
Scotiabank Maintains Sector Perform on Biomar...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on Bi...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Biomarin ...
Benzinga Newsdesk
BioMarin Pharmaceutical shares are trading lo...
Benzinga Newsdesk
Wednesday, April 24, 2024
BioMarin Pharmaceutical shares are trading lo...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Biomarin Pharmaceutical Raises FY2024 Adj EPS...
Benzinga Newsdesk
Biomarin Pharmaceutical Q1 Adj $0.71 May Not ...
Benzinga Newsdesk
Wednesday, April 03, 2024
Looking Into Biomarin Pharmaceutical's Recent Short Interest
Benzinga Insights
Thursday, March 21, 2024
Major Decision: Dennis Slamon Exercises Options, Realizing $50K At Biomarin Pharmaceutical
Benzinga Insights
Tuesday, March 12, 2024
New Data To Be Presented For BioMarin's VOXZO...
Benzinga Newsdesk
Friday, March 08, 2024
Massive Insider Trade At Biomarin Pharmaceutical
Benzinga Insights
Thursday, February 29, 2024
Canaccord Genuity Reiterates Hold on Biomarin...
Benzinga Newsdesk
Monday, February 26, 2024
BioMarin Complied With A U.S. Department Of J...
Benzinga Newsdesk
Friday, February 23, 2024
The Latest Analyst Ratings For Biomarin Pharmaceutical
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Bi...
Benzinga Newsdesk
RBC Capital Reiterates Sector Perform on Biom...
Benzinga Newsdesk
Thursday, February 22, 2024
Recap: Biomarin Pharmaceutical Q4 Earnings
Benzinga Insights
Biomarin Pharmaceutical Q4 2023 Adj EPS $0.49...
Benzinga Newsdesk
Earnings Scheduled For February 22, 2024
Benzinga Insights
Tuesday, February 06, 2024
BioMarin To Present ROCTAVIAN Data Highlighti...
Benzinga Newsdesk
Tuesday, January 30, 2024
Decoding 8 Analyst Evaluations For Biomarin Pharmaceutical
Benzinga Insights
Baird Maintains Outperform on Biomarin Pharma...
Benzinga Newsdesk
Thursday, December 21, 2023
Cracking The Code: Understanding Analyst Reviews For Biomarin Pharmaceutical
Benzinga Insights
Stifel Reiterates Buy on Biomarin Pharmaceuti...
Benzinga Newsdesk
Wednesday, December 20, 2023
Biomarin Pharmaceutical Announced Several Ini...
Benzinga Newsdesk
Tuesday, November 28, 2023
BioMarin Announces Agreement With German Heal...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch